CLN8 Gene - Ceroid Lipofuscinosis, Neuronal 8

CLN8 Gene

Introduction

Cln8 Gene Ceroid Lipofuscinosis, Neuronal 8 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

{{- <!-- CLN8 Gene Page - Ceroid Lipofuscinosis, Neuronal 8 --> -}} [@lonka2004]

<div class="infobox infobox-gene"> [@hirvasniemi2006]

| Attribute | Value | [@vines2001]
|-----------|-------|
| Gene Symbol | CLN8 |
| Gene Name | Ceroid Lipofuscinosis, Neuronal 8 |
| Official Full Name | CLN8, ER Storage Membrane Protein |
| Chromosomal Location | 8p23.2 |
| GRCh38 Coordinates | chr8:1,723,247-1,755,442 |
| NCBI Gene ID | 2055 |
| OMIM ID | 607897 |
| Ensembl ID | ENSG00000154164 |
| UniProt ID | Q9UHD2 |
| Gene Family | CLN8 family, ER membrane proteins |

</div>}

Overview

The CLN8 gene encodes an endoplasmic reticulum (ER) membrane protein that plays a critical role in ER-to-lysosome trafficking and lipid metabolism. CLN8 forms a functional complex with CLN6 to mediate the transport of lysosomal enzymes and other cargo. Mutations in CLN8 cause variant forms of neuronal ceroid lipofuscinosis (NCL), including the Turkish variant (late infantile) and Northern Epilepsy (progressive epilepsy with dementia)^[1].

Function

Protein Structure

CLN8 is a 286-amino acid transmembrane protein (32 kDa) localized to the ER membrane. It contains multiple transmembrane domains and cytosolic loops^[2].

Normal Physiological Roles

CLN8 Gene

Introduction

Cln8 Gene Ceroid Lipofuscinosis, Neuronal 8 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

{{- <!-- CLN8 Gene Page - Ceroid Lipofuscinosis, Neuronal 8 --> -}} [@lonka2004]

<div class="infobox infobox-gene"> [@hirvasniemi2006]

| Attribute | Value | [@vines2001]
|-----------|-------|
| Gene Symbol | CLN8 |
| Gene Name | Ceroid Lipofuscinosis, Neuronal 8 |
| Official Full Name | CLN8, ER Storage Membrane Protein |
| Chromosomal Location | 8p23.2 |
| GRCh38 Coordinates | chr8:1,723,247-1,755,442 |
| NCBI Gene ID | 2055 |
| OMIM ID | 607897 |
| Ensembl ID | ENSG00000154164 |
| UniProt ID | Q9UHD2 |
| Gene Family | CLN8 family, ER membrane proteins |

</div>}

Overview

The CLN8 gene encodes an endoplasmic reticulum (ER) membrane protein that plays a critical role in ER-to-lysosome trafficking and lipid metabolism. CLN8 forms a functional complex with CLN6 to mediate the transport of lysosomal enzymes and other cargo. Mutations in CLN8 cause variant forms of neuronal ceroid lipofuscinosis (NCL), including the Turkish variant (late infantile) and Northern Epilepsy (progressive epilepsy with dementia)^[1].

Function

Protein Structure

CLN8 is a 286-amino acid transmembrane protein (32 kDa) localized to the ER membrane. It contains multiple transmembrane domains and cytosolic loops^[2].

Normal Physiological Roles

• ER-Lysosome Trafficking: Mediates protein transport from ER to lysosomes
• Lysosomal Enzyme Trafficking: Regulates trafficking of soluble lysosomal enzymes
• Lipid Metabolism: Involved in ceramide and fatty acid homeostasis
• [Autophagy](/entities/autophagy): Participates in autophagic pathways
• Neuronal Function: Essential for neuronal survival

Molecular Interactions

CLN8 interacts with:

• CLN6 - ER-lysosomal trafficking complex
• COPII machinery - ER export
• Lysosomal enzymes - Trafficking partners
• ER quality control - Chaperone interactions

Disease Associations

CLN8 Disease (Variant Late Infantile NCL - Turkish Variant)

CLN8 mutations cause classic late infantile NCL in Turkish families^[1]:

| Feature | Onset | Progression |
|---------|-------|-------------|
| Seizures | 3-7 years | Myoclonic, generalized |
| Vision loss | 4-8 years | Progressive |
| Cognitive decline | 4-8 years | Progressive dementia |
| Motor dysfunction | 5-10 years | Ataxia, spasticity |
| Death | 10-20 years | Variable |

Northern Epilepsy (NE)

A specific CLN8 mutation (c.70C>G, p.R24G) causes Northern Epilepsy, found in Finnish families^[3]:

| Feature | Onset | Progression |
|---------|-------|-------------|
| Seizures | 5-10 years | Progressive |
| Cognitive decline | 10-20 years | Progressive dementia |
| Motor dysfunction | 15-25 years | Ataxia |
| Vision loss | Variable | Less prominent |
| Death | 30-50 years | Variable |

Common Mutations

| Mutation | Type | Effect | Disease |
|----------|------|--------|---------|
| c.70C>G (p.R24G) | Missense | Partial function | Northern Epilepsy |
| c.301G>A (p.G101S) | Missense | Severe loss | Turkish variant |
| c.1165G>A (p.E389K) | Missense | Severe loss | Late infantile |
| c.1253A>G (p.Y418C) | Missense | Severe loss | Late infantile |
| c.451dupC | Frameshift | Null | Late infantile |

Genotype-Phenotype Correlations

• p.R24G homozygous: Northern Epilepsy (milder)
• Severe missense/Null: Classic late infantile NCL
• Compound heterozygous: Variable

Expression Patterns

• Tissue Distribution: High in brain ([cortex](/brain-regions/cortex), cerebellum), retina
• Brain Regions: Predominant in [neurons](/entities/neurons)
• Cellular Localization: ER membrane
• Developmental Expression: Throughout development
• Transcript: 1.9 kb mRNA, 4 exons

Therapeutic Approaches

Current Treatments

• Anticonvulsants: Seizure management
• Supportive care: Multidisciplinary approach
• Physical/occupational therapy: Maintain function

Experimental Therapies

• Gene therapy: AAV-vector approaches in development
• Small molecule approaches: Being investigated
• Enzyme replacement: Challenging due to ER localization

Research Directions

Background

The study of Cln8 Gene Ceroid Lipofuscinosis, Neuronal 8 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [NCBI Gene: CLN8](https://www.ncbi.nlm.nih.gov/gene/2055)
• [OMIM: CLN8](https://www.omim.org/entry/607897)
• [UniProt: Q9UHD2](https://www.uniprot.org/uniprotkb/Q9UHD2)
• [Batten Disease Resource](https://www.bdsra.org/)
• [ClinicalTrials.gov: CLN8](https://clinicaltrials.gov/search?cond=CLN8)

References